Raluca Verona
Johnson & Johnson (United States)(US)Springhouse(US)Janssen (United States)(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immune cells in cancer, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Teclistamab in Relapsed or Refractory Multiple Myeloma(2022)1,022 cited
- → Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma(2022)599 cited
- → Selective loss of imprinting in the placenta following preimplantation development in culture(2004)429 cited
- → E2f3 is critical for normal cellular proliferation(2000)345 cited
- → Disruption of Imprinted Gene Methylation and Expression in Cloned Preimplantation Stage Mouse Embryos1(2003)311 cited
- → Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study(2021)298 cited